Linical Co., Ltd. Logo

Linical Co., Ltd.

A global CRO providing a full spectrum of drug development services for biopharma.

2183 | T

Overview

Corporate Details

ISIN(s):
JP3974530002
LEI:
Country:
Japan
Address:
大阪市淀川区宮原1丁目6番1号

Description

Linical is a global Contract Research Organization (CRO) providing a full spectrum of drug development services to biopharmaceutical companies. The company supports clinical trials from early-stage research to large-scale, multinational studies (Phase I-IV). Its services include clinical trial strategy, consulting, monitoring, and quality control. Linical focuses on a collaborative approach to guide clients through the clinical development process, aiming to expedite timelines and achieve enrollment goals without compromising quality.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 08:05
確認書
Japanese 8.1 KB
2025-11-14 08:04
半期報告書-第21期(2025/04/01-2026/03/31)
Japanese 160.5 KB
2025-06-26 09:36
臨時報告書
Japanese 24.4 KB
2025-06-24 09:27
内部統制報告書-第20期(2024/04/01-2025/03/31)
Japanese 22.7 KB
2025-06-24 09:26
確認書
Japanese 8.1 KB
2025-06-24 09:25
有価証券報告書-第20期(2024/04/01-2025/03/31)
Japanese 1.1 MB
2024-11-14 08:13
確認書
Japanese 8.0 KB
2024-11-14 08:09
半期報告書-第20期(2024/04/01-2025/03/31)
Japanese 180.6 KB
2024-06-27 09:29
臨時報告書
Japanese 23.6 KB
2024-06-27 09:28
内部統制報告書-第19期(2023/04/01-2024/03/31)
Japanese 21.7 KB
2024-06-27 09:26
確認書
Japanese 8.1 KB
2024-06-27 09:25
有価証券報告書-第19期(2023/04/01-2024/03/31)
Japanese 1.0 MB
2024-02-14 08:11
確認書
Japanese 8.1 KB
2024-02-14 08:10
四半期報告書-第19期第3四半期(2023/10/01-2023/12/31)
Japanese 153.3 KB
2023-11-14 08:09
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all Linical Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Linical Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Linical Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Adaptive Biotechnologies Corp Logo
Decodes the adaptive immune system to develop products for diagnosing and treating disease.
United States of America
ADPT
Adeia Inc. Logo
R&D company that licenses IP for the media, entertainment, and semiconductor industries.
United States of America
ADEA
Aditxt, Inc. Logo
Acquires, develops, and deploys health technologies to address major health challenges.
United States of America
ADTX
Advanced Biomed Inc. Logo
Develops microfluidic biochip diagnostic systems for precision oncology.
United States of America
ADVB
AIM ImmunoTech Inc. Logo
Immuno-pharma company developing therapeutics for oncology, immune, and viral diseases.
United States of America
AIM
Ainos, Inc. Logo
Develops AI-driven diagnostics, immune therapeutics, and telehealth POCT devices.
United States of America
AIMD
Akero Therapeutics, Inc. Logo
Clinical-stage company developing treatments for serious metabolic diseases like MASH.
United States of America
AKRO
Aladdin Healthcare Technologies SE Logo
Develops AI-powered tools for drug discovery and diagnostics for age-related conditions.
Germany
NMI
Alaunos Therapeutics, Inc. Logo
Clinical-stage immuno-oncology company developing TCR-T cell therapies for solid tumors.
United States of America
TCRT
Aligos Therapeutics, Inc. Logo
A clinical-stage biopharmaceutical company developing therapeutics for liver and viral diseases.
United States of America
ALGS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.